Physician

Sang Y Huh, MD

According to 2025 Medicare claims, Sang Huh, MD (NPI: 1194799742) practices hematology/oncology in the Terre Haute, IN market, with the plurality of this provider's patient population coming from Vigo, IN. This provider's primary affiliated billing organization is UNION HOSPITAL, INC. (NPI: 1013965573; TIN: 350876396) and primary practice location at 47802-3562. Huh is affiliated with the IRCCO (ACO ID: A2619), Central Florida ACO (ACO ID: A2801), and Collaborative ACO 30, LLC (ACO ID: A5483), participating under the MSSP model.

Huh's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 708 traditional Medicare patients, billed 2,141 HCPCS/CPT codes, and received $179,065 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 1,570 prescription claims across 288 beneficiaries totaling $3,292,361 in drug costs, led by Promacta (Eltrombopag Olamine). DME data shows 11 claims. Open Payments data shows 168 records totaling $3,585. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $1,827,624 to $3,292,361. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $24,203 to $136.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	929	3,077	$206,031
2016	935	3,130	$226,802
2017	947	3,507	$247,117
2018	973	3,497	$239,639
2019	1,024	4,236	$264,657
2020	911	3,094	$197,959
2021	876	2,775	$195,959
2022	840	2,645	$195,862
2023	806	2,425	$193,096
2024	708	2,141	$179,065

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	293	2,151	$1,827,624
2016	307	2,185	$1,456,262
2017	305	1,966	$1,234,350
2018	333	2,030	$2,054,570
2019	312	1,759	$1,870,060
2020	264	1,557	$2,969,588
2021	255	1,402	$3,102,224
2022	267	1,609	$2,757,220
2023	287	1,540	$3,248,701
2024	288	1,570	$3,292,361

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	23	348	$48,250
2016	16	140	$22,371
2017	14	108	$20,008
2018	14	73	$9,006
2019	11	45	$4,856
2020	N/R	40	$4,719
2021	N/R	12	$1,124
2022	N/R	11	$1,001
2023	N/R	N/R	N/R
2024	N/R	11	$101

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	120	230	$131
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	377	1,012	$91
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	327	404	$60
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	59	88	$58
99231	Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes	94	174	$36

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Promacta	Eltrombopag Olamine	37	1,110	$459,420
Revlimid	Lenalidomide	21	588	$377,100
Brukinsa	Zanubrutinib	24	720	$340,926
Jakafi	Ruxolitinib Phosphate	26	780	$339,423
Doptelet	Avatrombopag Maleate	14	538	$302,235

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E0570	Nebulizer, with compressor	Y	N/R	11	$101

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	168	$3,585	Novartis Pharmaceuticals Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Sang Y. Huh, MD?

Tedicare shows public-source Medicare data for Sang Y. Huh, MD (NPI 1194799742), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Sang Y. Huh, MD have ACO affiliation data?

Sang Y. Huh, MD is shown with ACO affiliation data for IRCCO (MSSP, ACO ID A2619), Central Florida ACO (MSSP, ACO ID A2801), and Collaborative ACO 30, LLC (MSSP, ACO ID A5483).

What billing organization is linked to Sang Y. Huh, MD?

Sang Y. Huh, MD is linked to UNION HOSPITAL, INC. (billing NPI 1013965573) in the available physician profile data.

Does Sang Y. Huh, MD have Open Payments data?

Sang Y. Huh, MD has 168 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.